High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptor

Experimental Hematology

Volumn 39, Issue 2, 2011, Pages

  Ando, Koji ^a   Miyazaki, Yasushi ^a   Sawayama, Yasushi ^a   Tominaga, Shinya ^a   Matsuo, Emi ^b   Yamasaki, Reishi ^a   Inoue, Yoriko ^a   Iwanaga, Masako ^a   Imanishi, Daisuke ^a   Tsushima, Hideki ^a   Fukushima, Takuya ^a   Imaizumi, Yoshitaka ^a   Taguchi, Jun ^a   Yoshida, Shinichiro ^b   Hata, Tomoko ^a   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; LACTATE DEHYDROGENASE; LAMININ; LAMININ RECEPTOR; SMALL INTERFERING RNA; STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CELL LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 78751532343     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.11.001     Document Type: Article

References (39)

1. Blank U., Karlsson G., Karlsson S. Signaling pathways governing stem-cell fate. Blood 2008, 111:492-503.
2. Klein G. The extracellular matrix of the hematopoietic microenviroment. Experientia 1995, 51:914-926.
3. Ayala F., Dewar R., Kieran M., Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 2009, 23:2233-2241.
4. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
5. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
6. David T., Scadden D.T. The stem cell niche in health and leukemic disease. Best Pract Res Clin Haematol 2007, 20:19-27.
7. Jin L., Hope K.J., Zhai Q., Smadja-Joffe F., Dick J.E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006, 12:1167-1174.
8. Krause D.S., Lazarides K., von Andrian U.H., Van Etten R.A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006, 12:1175-1180.
9. Matsunaga T., Takemoto N., Sato T., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003, 9:1158-1165.
10. Patarroyo M., Tryggvason K., Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 2002, 12:197-207.
11. Nelson J., Mcferran N.V., Pivato G., et al. The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 2008, 28:33-48.
12. Malinda K.M., Kleinman H.K. The Laminins. Int J Biochem 1996, 28:957-959.
13. Gu I., Sumida Y., Sanzen N., Sekiguchi K. Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130cas-CrkII-Dock180 Pathway. J Biol Chem 2001, 276:27090-27097.
14. Gu J., Fujibayashi A., Yamada K.M., Sekiguchi K. Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via PI3-kinase/Akt- and MEK1/ERK-dependent pathways. J Biol Chem 2002, 272:19922-19928.
15. Pulkinnen L., Christiano A.M., Airenne T., Haakana H., Tryggvason K., Uitto J. Mutations in the g2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bllosa. Nat Genet 1994, 6:293-298.
16. Helbling-Leclerc A., Zhang X., Topaloglu H., et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995, 11:216-218.
17. Iwamoto Y., Robey F.A., Graf J., et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987, 238:1132-1134.
18. Martignone S., Ménard S., Bufalino R., et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993, 85:398-402.
19. Satoh K., Narumi K., Abe T., et al. Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells. Br J Cancer 1999, 80:1115-1122.
20. Canfield S.M., Khakoo A.Y. The Nonintegrin laminin binding protein (p67 LBP) is expressed on a subset of activated human T lymphocytes and, together with the integrin very late activation antigen-6, mediates avid cellular adherence to laminin. J Immunol 1999, 163:3430-3440.
21. Selleri C., Ragno P., Ricci P., et al. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 2006, 108:2476-2484.
22. Bonig H., Chang K.H., Nakamoto B., Papayannopoulou T. The p67 laminin receptor identifies human erythroid progenitor and precursor cells and is functionally important for their bone marrow lodgment. Blood 2006, 108:1230-1233.
23. Montuori N., Selleri C., Risitano A.M., et al. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin Cancer Res 1999, 5:1465-1472.
24. Hill A.D., Naama H.A., Calvano S.E., Daly J.M. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leukocyte Biol 1995, 58:634-642.
25. Iwasaki-Arai J., Iwasaki H., Miyamoto T., Watanabe S., Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J Exp Med 2003, 197:1311-1322.
26. Chen J., Cárcamo J.M., Bórquez-Ojeda O., Erdjument-Bromage H., Tempst P., Golde D.W. The laminin receptor modulates granulocyte-macrophage colony-stimulating factor receptor complex formation and modulates its signaling. Proc Natl Acad Sci U S A 2003, 100:14000-14005.
27. Kitamura T., Tange T., Terasawa T., et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989, 140:323-334.
28. Lange B., Valtieri M., Santoli D., et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987, 70:192-199.
29. Miyawaki S., Sakamaki H., Ohtake S., et al. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study. Cancer 2005, 104:2726-2734.
30. Coffer P.J., Koenderman L., de Groot R.P. The role of STATs in myeloid differentiation and leukemia. Oncogene 2000, 19:2511-2522.
31. Gauczynski S., Peyrin J.M., Haïk S., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 2001, 20:5863-5875.
32. Barredaa D.R., Haningtona P.C., Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004, 28:509-554.
33. Jamieson K.V., Wu J., Hubbard S.R., Meruelo D. Crystal structure of the human laminin receptor precursor. J Biol Chem 2008, 283:3002-3005.
34. Hansen G., Hercus T.R., McClure B.J., et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134:496-507.
35. Koike K., Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia. Br J Haematol 2008, 141:567-575.
36. Kotecha N., Flores N.J., Irish J.M., Simonds E.F., Sakai D.S., Archambeault S. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 2008, 14:335-343.
37. Irish J.M., Hovland R., Krutzik P.O., et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004, 118:217-228.
38. Nakao M., Yokota S., Iwai T., et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996, 10:1911-1918.
39. Kiyoi H., Naoe T., Nakano Y., et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999, 93:3074-3080.